5 days ago
NRIX
AnalystsGregory RenzaGregory Renza's Stock Forecasts
AnalystsGregory Renza
Analyst Ranking
Top 3%
#140 out of 5323 analysts
Average Return
+22.11%
Win Rate
45%126 out of 283
Risk vs Reward
Poor
Good
Gregory Renza's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cidara Therapeutics IncCDTX | +1,088.30% | $18.63 | $221.38 | 2025-05-09 - 2026-01-06 | Buy |
Cidara Therapeutics IncCDTX | +864.38% | $22.88 | $220.65 | 2024-12-13 - 2025-12-12 | Buy |
Cidara Therapeutics IncCDTX | +811.78% | $24.28 | $221.38 | 2025-05-23 - 2026-01-06 | Buy |
Prometheus Biosciences IncRXDX | +603.13% | $27.52 | $193.50 | 2022-05-13 - 2023-04-18 | Buy |
Alpine Immune Sciences IncALPN | +428.30% | $12.19 | $64.40 | 2023-10-05 - 2024-04-11 | Buy |
Gregory Renza Analyst Color
Get additional color on Gregory Renza's coverage of popular stocks
9 days ago
ZYME
9 days ago
ONC
14 days ago
ABVX
16 days ago
VRDN
16 days ago
RVMD
a month ago
NRIX
2 months ago
RVMD
2 months ago
CGON
2 months ago
GILD
5 months ago
ONC
5 months ago
GILD
5 months ago
CGON
6 months ago
GILD
6 months ago
CGON
6 months ago
IDYA
8 months ago
CATX
8 months ago
NRIX
8 months ago
GILD
8 months ago
ONC
3 years ago
RXDX
Gregory Renza's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Nurix Therapeutics IncNRIX | 14 | Strong Buy | $34.00 | +47.95% | Maintains | 5 days ago |
Zymeworks IncZYME | 1 | Strong Buy | $31.00 | +25.71% | Maintains | 9 days ago |
Xencor IncXNCR | 11 | Strong Buy | $27.00 | +80.60% | Maintains | 9 days ago |
Nuvation Bio IncNUVB | 8 | Strong Buy | $13.00 | +120.34% | Maintains | 9 days ago |
Jazz Pharmaceuticals PLCJAZZ | 15 | Strong Buy | $254.00 | +6.70% | Maintains | 9 days ago |
Ideaya Biosciences IncIDYA | 15 | Strong Buy | $63.00 | +71.90% | Maintains | 9 days ago |
Gilead Sciences IncGILD | 5 | Strong Buy | $156.00 | +19.96% | Maintains | 9 days ago |
Exelixis IncEXEL | 13 | Hold | $56.00 | +0.41% | Maintains | 9 days ago |
Beone Medicines LtdONC | 6 | Strong Buy | $416.00 | +35.70% | Maintains | 9 days ago |
Agios Pharmaceuticals IncAGIO | 10 | Strong Buy | $41.00 | +2.71% | Maintains | 9 days ago |
Amgen IncAMGN | 21 | Hold | $340.00 | -4.29% | Maintains | 9 days ago |
Regeneron Pharmaceuticals IncREGN | 7 | Strong Buy | $769.00 | +17.20% | Maintains | 9 days ago |
Abivax SaABVX | 3 | Strong Buy | $155.00 | +14.89% | Maintains | 14 days ago |
Viridian Therapeutics IncVRDN | 15 | Strong Buy | $38.00 | +99.16% | Maintains | 16 days ago |
Revolution Medicines IncRVMD | 2 | Strong Buy | $210.00 | +13.53% | Maintains | 16 days ago |
Nuvalent IncNUVL | 2 | Hold | $124.00 | +0.03% | Downgrades | a month ago |
Fulcrum Therapeutics IncFULC | 6 | Hold | $4.00 | +11.42% | Downgrades | a month ago |
Cg Oncology IncCGON | 8 | Strong Buy | $82.00 | +14.25% | Reiterates | 2 months ago |
Perspective Therapeutics IncCATX | 7 | Strong Buy | $12.00 | +293.44% | Assumes | 8 months ago |
Mannkind CorpMNKD | 2 | Strong Buy | $9.00 | +131.96% | Initiates Coverage On | 8 months ago |
Bicycle Therapeutics PLCBCYC | 4 | Hold | $10.00 | +137.53% | Initiates Coverage On | 8 months ago |
Ascentage Pharma Group InternationalAAPG | 1 | Strong Buy | $51.00 | +165.07% | Initiates Coverage On | 8 months ago |
Cidara Therapeutics IncCDTX | 3 | Buy | $35.00 | N/A | Maintains | a year ago |
Acadia Pharmaceuticals IncACAD | 14 | Buy | $26.00 | N/A | Reiterates | a year ago |
Adc Therapeutics SaADCT | 12 | Buy | $8.00 | N/A | Reiterates | a year ago |
Inovio Pharmaceuticals IncINO | 11 | Hold | $5.00 | N/A | Reiterates | a year ago |
Spruce Biosciences IncSPRB | 13 | Hold | $0.50 | N/A | Maintains | a year ago |
Cormedix IncCRMD | 6 | Buy | $12.00 | N/A | Reiterates | a year ago |
Verastem IncVSTM | 10 | Buy | $14.00 | N/A | Maintains | a year ago |
Pacira Biosciences IncPCRX | 11 | Hold | $18.00 | N/A | Reiterates | 2 years ago |
Jasper Therapeutics IncJSPR | 4 | Buy | $48.00 | N/A | Maintains | 2 years ago |
Viracta Therapeutics IncVIRX | 8 | Buy | $2.00 | N/A | Maintains | 2 years ago |
Verrica Pharmaceuticals IncVRCA | 7 | Hold | $20.00 | N/A | Downgrades | 2 years ago |
Atyr Pharma IncATYR | 7 | Buy | $16.00 | N/A | Reiterates | 2 years ago |
Morphic Holding IncMORF | 7 | Hold | $57.00 | N/A | Reiterates | 2 years ago |
Alpine Immune Sciences IncALPN | 4 | Hold | $65.00 | N/A | Downgrades | 2 years ago |
Fusion Pharmaceuticals IncFUSN | 3 | Hold | $21.00 | N/A | Downgrades | 2 years ago |
Aptose Biosciences IncAPTOF | 7 | Buy | $540.00 | N/A | Maintains | 3 years ago |
Avalo Therapeutics IncAVTX | 4 | Hold | $180.00 | N/A | Downgrades | 3 years ago |
Bellus Health IncBLU | 8 | Hold | $14.75 | N/A | Reiterates | 3 years ago |
Prometheus Biosciences IncRXDX | 6 | Hold | $200.00 | N/A | Maintains | 3 years ago |
Seagen IncSGEN | 5 | Buy | $229.00 | N/A | Maintains | 3 years ago |
Global Blood Therapeutics IncGBT | 3 | Hold | $68.50 | N/A | Downgrades | 4 years ago |
Aprea Therapeutics IncAPRE | 5 | Hold | $80.00 | N/A | Maintains | 4 years ago |
Provention Bio IncPRVB | 2 | Hold | $10.00 | N/A | Downgrades | 5 years ago |
Iterum Therapeutics PLCITRMF | 3 | Hold | $30.00 | N/A | Downgrades | 6 years ago |
Portola Pharmaceuticals IncPTLA | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 6 years ago |
Arqule IncARQL | 1 | Hold | $20.00 | N/A | Downgrades | 7 years ago |
Gamida Cell LtdGMDAQ | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.